Drug Shortage Report for SUPEUDOL 20
| Report ID | 250522 |
| Drug Identification Number | 02262983 |
| Brand name | SUPEUDOL 20 |
| Common or Proper name | SUPEUDOL 20 |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | OXYCODONE HYDROCHLORIDE |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 50TAB |
| ATC code | N02AA |
| ATC description | OPIOIDS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | |
| Actual start date | 2025-02-17 |
| Estimated end date | 2025-07-18 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-02-17 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4600 RUE ARMAND-FRAPPIER SAINT-HUBERT, QUEBEC CANADA J3Z 1G5 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-02-17 | French | Compare |
| v1 | 2025-02-17 | English | Compare |
Showing 1 to 2 of 2